Open Access

PPWD1 is associated with the occurrence of postmenopausal osteoporosis as determined by weighted gene co‑expression network analysis

  • Authors:
    • Guo‑Feng Qian
    • Lu‑Shun Yuan
    • Min Chen
    • Dan Ye
    • Guo‑Ping Chen
    • Zhe Zhang
    • Cheng‑Jiang Li
    • Vijith Vijayan
    • Yu Xiao
  • View Affiliations

  • Published online on: August 7, 2019     https://doi.org/10.3892/mmr.2019.10570
  • Pages: 3202-3214
  • Copyright: © Qian et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Postmenopausal osteoporosis (PMO) is the most common type of primary osteoporosis (OP), a systemic skeletal disease. Although many factors have been revealed to contribute to the occurrence of PMO, specific biomarkers for the early diagnosis and therapy of PMO are not available. In the present study, a weighted gene co‑expression network analysis (WGCNA) was performed to screen gene modules associated with menopausal status. The turquoise module was verified as the clinically significant module, and 12 genes (NUP133, PSMD12, PPWD1, RBM8A, CRNKL1, PPP2R5C, RBM22, PIK3CB, SKIV2L2, PAPOLA, SRSF1 and COPS2) were identified as ‘real’ hub genes in both the protein‑protein interaction (PPI) network and co‑expression network. Furthermore, gene expression analysis by microarray in blood monocytes from pre‑ and post‑menopausal women revealed an increase in the expression of these hub genes in postmenopausal women. However, only the expression of peptidylprolyl isomerase domain and WD repeat containing 1 (PPWD1) was correlated with bone mineral density (BMD) in postmenopausal women. In the validation set, a similar expression pattern of PPWD1 was revealed. Functional enrichment analysis revealed that the fatty acid metabolism pathway was significantly abundant in the samples that exhibited a higher expression of PPWD1. Collectively, PPWD1 is indicated as a potential diagnostic biomarker for the occurrence of PMO.

Related Articles

Journal Cover

October 2019
Volume 20 Issue 4

Print ISSN: 1791-2997
Online ISSN:1791-3004

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
APA
Qian, G., Yuan, L., Chen, M., Ye, D., Chen, G., Zhang, Z. ... Xiao, Y. (2019). PPWD1 is associated with the occurrence of postmenopausal osteoporosis as determined by weighted gene co‑expression network analysis. Molecular Medicine Reports, 20, 3202-3214. https://doi.org/10.3892/mmr.2019.10570
MLA
Qian, G., Yuan, L., Chen, M., Ye, D., Chen, G., Zhang, Z., Li, C., Vijayan, V., Xiao, Y."PPWD1 is associated with the occurrence of postmenopausal osteoporosis as determined by weighted gene co‑expression network analysis". Molecular Medicine Reports 20.4 (2019): 3202-3214.
Chicago
Qian, G., Yuan, L., Chen, M., Ye, D., Chen, G., Zhang, Z., Li, C., Vijayan, V., Xiao, Y."PPWD1 is associated with the occurrence of postmenopausal osteoporosis as determined by weighted gene co‑expression network analysis". Molecular Medicine Reports 20, no. 4 (2019): 3202-3214. https://doi.org/10.3892/mmr.2019.10570